Nobel laureates are calling on the National Academies and biotech CEOs to speak out against what they see as the Trump ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

Potential impacts of the tariffs include higher prices for drugs and medical supplies, and possible shortages.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

Sens. Elizabeth Warren and Ron Wyden criticized RFK Jr. over how he's handling potential profits from litigation over an HPV ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Public health expert Emily Abel discusses with STAT the challenges to finding truly gluten-free foods, the topic of her new ...

Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft ...

Under the proposal, if West Virginia can reduce its obesity rate to under 25% (the rate in Colorado and Hawaii, our leanest ...

The NSF said on Sunday that its payment system was back on line, after it froze out researchers and sparked financial worries ...